Investment Research & Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.4K | Hold |
1,650
| – | – | 0.03% | 97 |
|
|
2025
Q1 | $101K | Buy |
1,650
+750
| +83% | +$45.7K | 0.04% | 92 |
|
|
2024
Q4 | $50.9K | Buy |
+900
| New | +$50.9K | 0.02% | 106 |
|
|
2024
Q2 | – | Sell |
-1,170
| Closed | -$63.4K | – | 208 |
|
|
2024
Q1 | $63.4K | Hold |
1,170
| – | – | 0.03% | 92 |
|
|
2023
Q4 | $60K | Hold |
1,170
| – | – | 0.03% | 91 |
|
|
2023
Q3 | $67.9K | Hold |
1,170
| – | – | 0.04% | 88 |
|
|
2023
Q2 | $74.8K | Hold |
1,170
| – | – | 0.04% | 88 |
|
|
2023
Q1 | $81.1K | Hold |
1,170
| – | – | 0.05% | 84 |
|
|
2022
Q4 | $84.2K | Hold |
1,170
| – | – | 0.06% | 81 |
|
|
2022
Q3 | $83K | Hold |
1,170
| – | – | 0.06% | 78 |
|
|
2022
Q2 | $90K | Hold |
1,170
| – | – | 0.07% | 83 |
|
|
2022
Q1 | $85K | Hold |
1,170
| – | – | 0.05% | 93 |
|
|
2021
Q4 | $73K | Hold |
1,170
| – | – | 0.04% | 99 |
|
|
2021
Q3 | $70K | Sell |
1,170
-135
| -10% | -$8.08K | 0.05% | 92 |
|
|
2021
Q2 | $87K | Buy |
1,305
+135
| +12% | +$9K | 0.06% | 95 |
|
|
2021
Q1 | $74K | Hold |
1,170
| – | – | 0.05% | 88 |
|
|
2020
Q4 | $73K | Hold |
1,170
| – | – | 0.05% | 88 |
|
|
2020
Q3 | $71K | Hold |
1,170
| – | – | 0.06% | 87 |
|
|
2020
Q2 | $68K | Hold |
1,170
| – | – | 0.06% | 83 |
|
|
2020
Q1 | $65K | Hold |
1,170
| – | – | 0.06% | 81 |
|
|
2019
Q4 | $75K | Buy |
+1,170
| New | +$75K | 0.07% | 86 |
|